Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
Total Valuation
LifeMD has a market cap or net worth of $171.36M. The enterprise value is $298.24M.
Market Cap$171.36M
Enterprise Value$298.24M
Share Statistics
LifeMD has 48,135,883 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48,135,883
Owned by Insiders16.60%
Owned by Institutions5.17%
Financial Efficiency
LifeMD’s return on equity (ROE) is 3.44 and return on invested capital (ROIC) is -77.98%.
Return on Equity (ROE)3.44
Return on Assets (ROA)-0.26
Return on Invested Capital (ROIC)-77.98%
Return on Capital Employed (ROCE)-1.32
Revenue Per Employee698.86K
Profits Per Employee-61.61K
Employee Count304
Asset Turnover2.93
Inventory Turnover8.60
Valuation Ratios
The current PE Ratio of LifeMD is ―. LifeMD’s PEG ratio is 0.44.
PE Ratio―
PS Ratio0.96
PB Ratio-37.17
Price to Fair Value-37.17
Price to FCF34.12
Price to Operating Cash Flow13.82
PEG Ratio0.44
Income Statement
In the last 12 months, LifeMD had revenue of 212.45M and earned -18.88M in profits. Earnings per share was -0.53.
Revenue212.45M
Gross Profit188.39M
Operating Income-16.14M
Pretax Income-18.33M
Net Income-18.88M
EBITDA-6.65M
Earnings Per Share (EPS)-0.53
Cash Flow
In the last 12 months, operating cash flow was 13.13M and capital expenditures 3.85M, giving a free cash flow of 16.98M billion.
Operating Cash Flow13.13M
Free Cash Flow16.98M
Free Cash Flow per Share0.35
Dividends & Yields
LifeMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.52
52-Week Price Change-31.99%
50-Day Moving Average5.54
200-Day Moving Average7.60
Relative Strength Index (RSI)27.20
Average Volume (3m)1.31M
Important Dates
LifeMD upcoming earnings date is Mar 16, 2026, Before Open (Confirmed).
Last Earnings DateNov 17, 2025
Next Earnings DateMar 16, 2026
Ex-Dividend Date―
Financial Position
LifeMD as a current ratio of 0.81, with Debt / Equity ratio of 496.46%
Current Ratio0.81
Quick Ratio0.76
Debt to Market Cap0.09
Net Debt to EBITDA0.67
Interest Coverage Ratio-7.40
Taxes
In the past 12 months, LifeMD has paid 402.00K in taxes.
Income Tax402.00K
Effective Tax Rate-0.02
Enterprise Valuation
LifeMD EV to EBITDA ratio is -13.22, with an EV/FCF ratio of 32.46.
EV to Sales0.91
EV to EBITDA-13.22
EV to Free Cash Flow32.46
EV to Operating Cash Flow11.08
Balance Sheet
LifeMD has $23.79M in cash and marketable securities with $6.53M in debt, giving a net cash position of $17.26M billion.
Cash & Marketable Securities$23.79M
Total Debt$6.53M
Net Cash$17.26M
Net Cash Per Share$0.36
Tangible Book Value Per Share-$0.48
Margins
Gross margin is 91.64%, with operating margin of -7.60%, and net profit margin of -8.89%.
Gross Margin91.64%
Operating Margin-7.60%
Pretax Margin-8.63%
Net Profit Margin-8.89%
EBITDA Margin-6.91%
EBIT Margin-7.60%
Analyst Forecast
The average price target for LifeMD is $9.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$9.67
Price Target Upside159.95% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast30.71%
EPS Growth Forecast73.43%